Nanoparticle-based nose-to-brain delivery of small RNA mediates downregulation of alpha-synuclein in a Parkinson's disease mouse model
Cite
Citation style:
Could not load citation form.
Access Statistic

Rights
Use and reproduction:
All rights reserved
